
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PPH market cap is 705.83M. The company's latest EPS is USD 12.2871 and P/E is 7.52.
Quarter End | Mar 2012 | ||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.38M | ||||
Operating Income | 0 | ||||
Net Income | 2.12M |
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 4.21M | 5.62M | 8.92M | 10.39M | 12.33M |
Operating Income | 0 | 0 | 0 | 0 | 0 |
Net Income | 28.27M | 41.02M | -57.82M | 92.32M | 93.85M |
Quarter End | Mar 2012 | ||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 262.54M | ||||
Total Liabilities | 1.24M | ||||
Total Equity | 261.29M |
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 237.56M | 340M | 580.24M | 448.42M | 768.69M |
Total Liabilities | 2.41M | 21.06M | 56.5M | 18.37M | 42.16M |
Total Equity | 235.15M | 318.94M | 523.74M | 430.05M | 726.53M |
Quarter End | Mar 2012 | ||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | ||||
Investing | N/A | ||||
Financing | N/A |
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | N/A | N/A | N/A | N/A |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | N/A | N/A | N/A | N/A |
Market Cap | 705.83M |
Price to Earnings Ratio | 7.52 |
Price to Sales Ratio | 57.27 |
Price to Cash Ratio | 1.6k |
Price to Book Ratio | 0.97 |
Dividend Yield | - |
Shares Outstanding | 7.64M |
Average Volume (1 week) | 404.84k |
Average Volume (1 Month) | 401.22k |
52 Week Change | 2.73% |
52 Week High | 99.51 |
52 Week Low | 84.4779 |
Spread (Intraday) | 6.42 (6.54%) |
Company Name | VanEck Pharmaceuticals ETF |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.vaneck.com |
Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions